These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2. Kuhrt K IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218 [TBL] [Abstract][Full Text] [Related]
5. Innovation strategies for generic drug companies: moving into supergenerics. Ross MS IDrugs; 2010 Apr; 13(4):243-7. PubMed ID: 20373253 [TBL] [Abstract][Full Text] [Related]
6. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1. Kuhrt K; Chace-Ortiz M IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217 [TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK. Beecher N IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274 [No Abstract] [Full Text] [Related]
9. 13th EGA annual conference. Challenges in the European and global environment for the generic medicines industry. Kuhrt K IDrugs; 2007 Aug; 10(8):549-53. PubMed ID: 17665329 [No Abstract] [Full Text] [Related]
10. SuperGenerics: a better alternative for biogenerics. Charles SA Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591 [No Abstract] [Full Text] [Related]
11. Pharmaceutical patent challenges--time for reassessment? Glass G Nat Rev Drug Discov; 2004 Dec; 3(12):1057-62. PubMed ID: 15573104 [TBL] [Abstract][Full Text] [Related]
13. Biosimilars and innovation: an analysis of the possibility of increased competition in biopharmaceuticals. Blackstone EA; Fuhr JP Future Med Chem; 2010 Nov; 2(11):1641-9. PubMed ID: 21428836 [TBL] [Abstract][Full Text] [Related]
14. Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience. Bocquet F; Loubière A; Fusier I; Cordonnier AL; Paubel P Pharmacoeconomics; 2016 Nov; 34(11):1173-1186. PubMed ID: 27412251 [TBL] [Abstract][Full Text] [Related]
15. Patent Cliffs in the Era of Complex Therapies and Biologics. Sabatini MT; Silva M Pharmaceut Med; 2020 Aug; 34(4):271-278. PubMed ID: 32772314 [TBL] [Abstract][Full Text] [Related]
17. Advances and Progress in Drug Design - SMi's ninth annual meeting. Welchman R IDrugs; 2010 Apr; 13(4):239-42. PubMed ID: 20373252 [TBL] [Abstract][Full Text] [Related]
18. Biosimilars in the United States: Emerging Issues in Litigation. Wong AY; Rumore MM; Chan AW BioDrugs; 2017 Jun; 31(3):189-205. PubMed ID: 28424972 [TBL] [Abstract][Full Text] [Related]
19. Stem Cells - SMi's second annual conference: achieving success in science and commercialisation. Lucifero D IDrugs; 2010 Apr; 13(4):232-4. PubMed ID: 20373250 [TBL] [Abstract][Full Text] [Related]